Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-08 3:14 pm Purchase |
2025-03-31 | 13G | Bright Minds Biosciences Inc. DRUG |
Sio Capital Management, LLC | 507,562 7.210% |
55,769 (+12.34%) |
Filing History |
| 2025-04-07 4:07 pm Purchase |
2025-03-31 | 13G | Bright Minds Biosciences Inc. DRUG |
JANUS HENDERSON GROUP PLC JHG |
1,111,368 16.000% |
306,392 (+38.06%) |
Filing History |
| 2025-02-14 4:06 pm Sale |
2024-12-31 | 13G | Bright Minds Biosciences Inc. DRUG |
Point72 Asset Management, L.P. | 135,189 3.000% |
-299,811 (-68.92%) |
Filing History |
| 2025-02-14 4:05 pm Purchase |
2024-12-31 | 13G | Nkarta, Inc. NKTX |
Commodore Capital LP | 351,848 0.500% |
351,848 (New Position) |
Filing History |
| 2025-02-14 4:05 pm Purchase |
2024-12-31 | 13G | Celcuity Inc. CELC |
Commodore Capital LP | 1,095,650 2.900% |
1,095,650 (New Position) |
Filing History |
| 2025-02-14 4:05 pm Purchase |
2024-12-31 | 13G | Bright Minds Biosciences Inc. DRUG |
Commodore Capital LP | 500,000 7.200% |
100,000 (+25.00%) |
Filing History |
| 2025-02-10 12:56 pm Purchase |
2024-12-31 | 13G | Bright Minds Biosciences Inc. DRUG |
Sio Capital Management, LLC | 451,793 6.500% |
451,793 (New Position) |
Filing History |
| 2025-02-07 10:49 am Purchase |
2025-01-31 | 13G | Bright Minds Biosciences Inc. DRUG |
JANUS HENDERSON GROUP PLC JHG |
804,976 11.600% |
804,976 (New Position) |
Filing History |
| 2024-11-12 4:15 pm Purchase |
2024-11-04 | 13G | Bright Minds Biosciences Inc. DRUG |
RA Capital Management, L.P. | 460,829 6.600% |
460,829 (New Position) |
Filing History |
| 2024-11-06 4:06 pm Purchase |
2024-11-04 | 13G | Bright Minds Biosciences Inc. DRUG |
Cormorant Asset Management LP | 1,059,331 17.260% |
184,331 (+21.07%) |
Filing History |
| 2024-11-05 3:25 pm Unchanged |
2024-10-30 | 13D | Bright Minds Biosciences Inc. DRUG |
McDonald Ian | 1,364,900 23.700% |
0 (Unchanged) |
Filing History |
| 2024-11-05 3:21 pm Sale |
2024-10-16 | 13D | Bright Minds Biosciences Inc. DRUG |
McDonald Ian | 1,364,900 24.400% |
-201,610 (-12.87%) |
Filing History |
| 2024-10-25 4:05 pm Purchase |
2024-10-18 | 13G | Bright Minds Biosciences Inc. DRUG |
Commodore Capital LP | 400,000 9.000% |
400,000 (New Position) |
Filing History |
| 2024-10-23 6:09 pm Purchase |
2024-10-16 | 13G | Bright Minds Biosciences Inc. DRUG |
Logos Global Management LP | 100,000 2.200% |
100,000 (New Position) |
Filing History |
| 2024-10-23 6:01 pm Purchase |
2024-10-16 | 13G | Bright Minds Biosciences Inc. DRUG |
Point72 Asset Management, L.P. | 435,000 9.700% |
435,000 (New Position) |
Filing History |
| 2024-10-22 4:03 pm Purchase |
2024-10-15 | 13G | Bright Minds Biosciences Inc. DRUG |
Cormorant Asset Management LP | 875,000 18.790% |
875,000 (New Position) |
Filing History |
| 2024-10-22 4:02 pm Unchanged |
2024-10-15 | 13G | Bright Minds Biosciences Inc. DRUG |
PFM Health Sciences, LP | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-10-16 1:14 pm Purchase |
2024-10-14 | 13G | Bright Minds Biosciences Inc. DRUG |
PERCEPTIVE ADVISORS LLC | 430,000 9.600% |
430,000 (New Position) |
Filing History |
| 2024-02-26 8:18 pm Purchase |
2023-12-22 | 13D | Bright Minds Biosciences Inc. DRUG |
McDonald Ian | 1,566,510 30.560% |
1,353,530 (+635.52%) |
Filing History |
| 2024-02-26 8:10 pm Purchase |
2022-12-01 | 13D | Bright Minds Biosciences Inc. DRUG |
McDonald Ian | 212,980 8.880% |
33,900 (+18.93%) |
Filing History |